Guo, X.; Sun, H.; Yu, F.; Feng, Y.; Guo, S.; Lei, J.H.; Miao, K.; Ip, K.-U.; Li, L.; Li, H.;
et al. Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling. Biomedicines 2025, 13, 2888.
https://doi.org/10.3390/biomedicines13122888
AMA Style
Guo X, Sun H, Yu F, Feng Y, Guo S, Lei JH, Miao K, Ip K-U, Li L, Li H,
et al. Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling. Biomedicines. 2025; 13(12):2888.
https://doi.org/10.3390/biomedicines13122888
Chicago/Turabian Style
Guo, Xinyu, Heng Sun, Feng Yu, Yangyang Feng, Sen Guo, Josh Haipeng Lei, Kai Miao, Ka-U Ip, Ling Li, Hanghang Li,
and et al. 2025. "Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling" Biomedicines 13, no. 12: 2888.
https://doi.org/10.3390/biomedicines13122888
APA Style
Guo, X., Sun, H., Yu, F., Feng, Y., Guo, S., Lei, J. H., Miao, K., Ip, K.-U., Li, L., Li, H., Liao, X., Xu, X., Zhou, R., & Deng, C.-X.
(2025). Dasatinib Inhibits Basal B Breast Cancer Through ETS1-Mediated Extracellular Matrix Remodeling. Biomedicines, 13(12), 2888.
https://doi.org/10.3390/biomedicines13122888